SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Chang-I. Chen, Ching-Feng Kuan, Yu-Ann Fang, Shing-Hwa Liu, Ju-Chi Liu, Li-Li Wu, Chun-Jen Chang, Hsuan-Chia Yang, Jaulang Hwang, James S. Miser, Szu-Yuan Wu, Cancer Risk in HBV Patients With Statin and Metformin Use, Medicine, 2015, 94, 6, e462

    CrossRef

  2. 2
    Kohei Oda, Hirofumi Uto, Seiichi Mawatari, Akio Ido, Clinical features of hepatocellular carcinoma associated with nonalcoholic fatty liver disease: a review of human studies, Clinical Journal of Gastroenterology, 2015, 8, 1, 1

    CrossRef

  3. 3
    Kelly J. Lafaro, Aram N. Demirjian, Timothy M. Pawlik, Epidemiology of Hepatocellular Carcinoma, Surgical Oncology Clinics of North America, 2015, 24, 1, 1

    CrossRef

  4. 4
    Katherine A. McGlynn, Jessica L. Petrick, W. Thomas London, Global Epidemiology, Clinics in Liver Disease, 2015,

    CrossRef

  5. You have free access to this content5
    S.-C. Fu, Y.-W. Huang, T.-C. Wang, J.-T. Hu, D.-S. Chen, S.-S. Yang, Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with new onset diabetes: a nationwide cohort study, Alimentary Pharmacology & Therapeutics, 2015, 41, 10
  6. 6
    Yuedan Liu, Yi Luo, Xiaoling Li, Wenjie Zheng, Tianfeng Chen, Rational Design of Selenadiazole Derivatives to Antagonize Hyperglycemia-Induced Drug Resistance in Cancer Cells, Chemistry – An Asian Journal, 2015, 10, 3
  7. 7
    Ross C. McLean, Jennifer Logue, The Individual and Combined Effects of Obesity and Type 2 Diabetes on Cancer Predisposition and Survival, Current Nutrition Reports, 2015, 4, 1, 22

    CrossRef

  8. 8
    K W Hagberg, K A McGlynn, V V Sahasrabuddhe, S Jick, Anti-diabetic medications and risk of primary liver cancer in persons with type II diabetes, British Journal of Cancer, 2014, 111, 9, 1710

    CrossRef

  9. 9
    Shi Sen, Yanzheng He, Daisuke Koya, Keizo Kanasaki, Cancer biology in diabetes, Journal of Diabetes Investigation, 2014, 5, 3
  10. 10
    Hiroki Nishikawa, Yukio Osaki, Hideyuki Komekado, Azusa Sakamoto, Sumio� Saito, Norihiro Nishijima, Akihiro Nasu, Akira Arimoto, Ryuichi Kita, Toru Kimura, Clinical significance of the FIB-4 index for non-B non-C hepatocellular carcinoma treated with surgical resection, Oncology Reports, 2014,

    CrossRef

  11. 11
    Takuma Arai, Shingo Akita, Masahiro Sakon, Taishi Fujii, Haruki Tanaka, Keiko Ishii, Shiro Miwa, Hepatocellular carcinoma associated with sarcoidosis, International Journal of Surgery Case Reports, 2014, 5, 8, 562

    CrossRef

  12. 12
    Yukari Totsuka, Tetsushi Watanabe, Souleymane Coulibaly, Sae Kobayashi, Marina Nishizaki, Miho Okazaki, Tomohiro Hasei, Keiji Wakabayashi, Hitoshi Nakagama, In vivo genotoxicity of a novel heterocyclic amine, aminobenzoazepinoquinolinone-derivative (ABAQ), produced by the Maillard reaction between glucose and l-tryptophan, Mutation Research/Genetic Toxicology and Environmental Mutagenesis, 2014, 760, 48

    CrossRef

  13. 13
    Willi Oberaigner, Christoph Ebenbichler, Karin Oberaigner, Martin Juchum, Hans Schönherr, Monika Lechleitner, Increased cancer incidence risk in type 2 diabetes mellitus: results from a cohort study in Tyrol/Austria, BMC Public Health, 2014, 14, 1, 1058

    CrossRef

  14. 14
    Wen-Qing Li, Yikyung Park, Katherine A. McGlynn, Albert R. Hollenbeck, Philip R. Taylor, Alisa M. Goldstein, Neal D. Freedman, Index-based dietary patterns and risk of incident hepatocellular carcinoma and mortality from chronic liver disease in a prospective study, Hepatology, 2014, 60, 2
  15. 15
    Caiyun Liao, Dongyu Zhang, Chemtai Mungo, D. Andrew Tompkins, Amer M. Zeidan, Is diabetes mellitus associated with increased incidence and disease-specific mortality in endometrial cancer? A systematic review and meta-analysis of cohort studies, Gynecologic Oncology, 2014, 135, 1, 163

    CrossRef

  16. 16
    E. Mullner, H. Brath, A. Nersesyan, M. Nitz, A. Petschnig, M. Wallner, S. Knasmuller, K.-H. Wagner, Nuclear anomalies in exfoliated buccal cells in healthy and diabetic individuals and the impact of a dietary intervention, Mutagenesis, 2014, 29, 1, 1

    CrossRef

  17. 17
    Antonio Vavallo, Simona Simone, Giuseppe Lucarelli, Monica Rutigliano, Vanessa Galleggiante, Giuseppe Grandaliano, Loreto Gesualdo, Marcello Campagna, Marica Cariello, Elena Ranieri, Giovanni Pertosa, Gaetano Lastilla, Francesco Paolo Selvaggi, Pasquale Ditonno, Michele Battaglia, Pre-existing Type 2 Diabetes Mellitus Is an Independent Risk Factor for Mortality and Progression in Patients With Renal Cell Carcinoma, Medicine, 2014, 93, 27, e183

    CrossRef

  18. 18
    Ashish Kumar, Subrat K. Acharya, Shivaram P. Singh, Vivek A. Saraswat, Anil Arora, Ajay Duseja, Mahesh K. Goenka, Deepali Jain, Premashish Kar, Manoj Kumar, Vinay Kumaran, Kunisshery M. Mohandas, Dipanjan Panda, Shashi B. Paul, Jeyamani Ramachandran, Hariharan Ramesh, Padaki N. Rao, Samir R. Shah, Hanish Sharma, Ragesh B. Thandassery, The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations, Journal of Clinical and Experimental Hepatology, 2014, 4, S3

    CrossRef

  19. 19
    Wael Al-Zhoughbi, Jianfeng Huang, Ganapathy S. Paramasivan, Holger Till, Martin Pichler, Barbara Guertl-Lackner, Gerald Hoefler, Tumor Macroenvironment and Metabolism, Seminars in Oncology, 2014, 41, 2, 281

    CrossRef

  20. 20
    Siddharth Singh, Preet Paul Singh, Abha Goyal Singh, Mohammad Hassan Murad, William Sanchez, Anti-Diabetic Medications and the Risk of Hepatocellular Cancer: A Systematic Review and Meta-Analysis, The American Journal of Gastroenterology, 2013, 108, 6, 881

    CrossRef

  21. 21
    I. N. Colmers, S. R. Majumdar, Y. Yasui, S. L. Bowker, C. A. Marra, J. A. Johnson, Detection Bias and Overestimation of Bladder Cancer Risk in Type 2 Diabetes: A matched cohort study, Diabetes Care, 2013, 36, 10, 3070

    CrossRef

  22. 22
    Samy L. Habib, Maciej Rojna, Diabetes and Risk of Cancer, ISRN Oncology, 2013, 2013, 1

    CrossRef

  23. You have full text access to this Open Access content23
    Shizuka Sasazuki, Hadrien Charvat, Azusa Hara, Kenji Wakai, Chisato Nagata, Kozue Nakamura, Ichiro Tsuji, Yumi Sugawara, Akiko Tamakoshi, Keitaro Matsuo, Isao Oze, Tetsuya Mizoue, Keitaro Tanaka, Manami Inoue, Shoichiro Tsugane, Diabetes mellitus and cancer risk: Pooled analysis of eight cohort studies in Japan, Cancer Science, 2013, 104, 11
  24. You have full text access to this Open Access content24
    Kentaro Shikata, Toshiharu Ninomiya, Yutaka Kiyohara, Diabetes mellitus and cancer risk: Review of the epidemiological evidence, Cancer Science, 2013, 104, 1
  25. 25
    Kozue Nakamura, Keiko Wada, Yuya Tamai, Michiko Tsuji, Toshiaki Kawachi, Akihiro Hori, Naoharu Takeyama, Shinobu Tanabashi, Shogen Matsushita, Naoki Tokimitsu, Chisato Nagata, Diabetes mellitus and risk of cancer in Takayama: A population-based prospective cohort study in Japan, Cancer Science, 2013, 104, 10
  26. 26
    S. Schlesinger, K. Aleksandrova, T. Pischon, M. Jenab, V. Fedirko, E. Trepo, K. Overvad, N. Roswall, A. Tjonneland, M. C. Boutron-Ruault, G. Fagherazzi, A. Racine, R. Kaaks, V. A. Grote, H. Boeing, A. Trichopoulou, M. Pantzalis, M. Kritikou, A. Mattiello, S. Sieri, C. Sacerdote, D. Palli, R. Tumino, P. H. Peeters, H. B. Bueno-de-Mesquita, E. Weiderpass, J. R. Quiros, R. Zamora-Ros, M. J. Sanchez, L. Arriola, E. Ardanaz, M. J. Tormo, P. Nilsson, B. Lindkvist, M. Sund, O. Rolandsson, K. T. Khaw, N. Wareham, R. C. Travis, E. Riboli, U. Nothlings, Diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort, Annals of Oncology, 2013, 24, 9, 2449

    CrossRef

  27. 27
    Jing Ding, Jie Tang, Xin Chen, Hai-Tao Men, Wu-Xia Luo, Yang Du, Jun Ge, Cong Li, Ye Chen, Ke Cheng, Meng Qiu, Ji-Yan Liu, Expression Characteristics of Proteins of the Insulin-like Growth Factor Axis in Non-small Cell Lung Cancer Patients with Preexisting Type 2 Diabetes Mellitus, Asian Pacific Journal of Cancer Prevention, 2013, 14, 10, 5675

    CrossRef

  28. 28
    E. Mullner, H. Brath, D. Toferer, S. Adrigan, M.-T. Bulla, R. Stieglmayer, M. Wallner, R. Marek, K.-H. Wagner, Genome damage in peripheral blood lymphocytes of diabetic and non-diabetic individuals after intervention with vegetables and plant oil, Mutagenesis, 2013, 28, 2, 205

    CrossRef

  29. 29
    Marc Rendell, Halis Kaan Akturk, Sri Harsha Tella, Glargine safety, diabetes and cancer, Expert Opinion on Drug Safety, 2013, 12, 2, 247

    CrossRef

  30. 30
    Albert J. Czaja, Hepatocellular Carcinoma and Other Malignancies in Autoimmune Hepatitis, Digestive Diseases and Sciences, 2013, 58, 6, 1459

    CrossRef

  31. 31
    Luca Montesi, Arianna Mazzotti, Simona Moscatiello, Gabriele Forlani, Giulio Marchesini, Insulin resistance: mechanism and implications for carcinogenesis and hepatocellular carcinoma in NASH, Hepatology International, 2013, 7, S2, 814

    CrossRef

  32. 32
    Raghuwansh P. Sah, Sajan Jiv Singh Nagpal, Debabrata Mukhopadhyay, Suresh T. Chari, New insights into pancreatic cancer-induced paraneoplastic diabetes, Nature Reviews Gastroenterology & Hepatology, 2013, 10, 7, 423

    CrossRef

  33. 33
    Romina Lomonaco, Nishanth E. Sunny, Fernando Bril, Kenneth Cusi, Nonalcoholic Fatty Liver Disease: Current Issues and Novel Treatment Approaches, Drugs, 2013, 73, 1, 1

    CrossRef

  34. 34
    M.P. Lutz, C. Mai, M. Hoffmann-Cornely, Pankreaskarzinom und andere gastrointestinale Tumoren bei Diabetes mellitus, Der Diabetologe, 2013, 9, 7, 551

    CrossRef

  35. 35
    Daniela Schmid, Gundula Behrens, Carmen Jochem, Marlen Keimling, Michael Leitzmann, Physical activity, diabetes, and risk of thyroid cancer: a systematic review and meta-analysis, European Journal of Epidemiology, 2013, 28, 12, 945

    CrossRef

  36. 36
    Tania M Welzel, Barry I Graubard, Sabah Quraishi, Stefan Zeuzem, Jessica A Davila, Hashem B El-Serag, Katherine A McGlynn, Population-Attributable Fractions of Risk Factors for Hepatocellular Carcinoma in the United States, The American Journal of Gastroenterology, 2013, 108, 8, 1314

    CrossRef

  37. 37
    Ichiro Yamato, Tadatoshi Takayama, Yutaka Midorikawa, Tokio Higaki, Hisashi Nakayama, Masamichi Moriguchi, Yoshiyuki Nakajima, Shunichi Matsuoka, Masahiro Ogawa, Mitsuhiko Moriyama, Postoperative outcomes of patients with hepatocellular carcinoma negative for all virus-related markers, Surgery Today, 2013, 43, 8, 865

    CrossRef

  38. 38
    Changhyun Lee, Jong In Yang, Hee Jin Byun, Jung Mook Kang, Seoungho Choi, Jeong Yoon Yim, Status of Primary Liver Cancer Found through Routine Health Check-up, Journal of Korean Medical Science, 2013, 28, 10, 1449

    CrossRef

  39. 39
    Etan Orgel, Steven D. Mittelman, The Links Between Insulin Resistance, Diabetes, and Cancer, Current Diabetes Reports, 2013, 13, 2, 213

    CrossRef

  40. 40
    Marni Stott-Miller, Chu Chen, Stephen M. Schwartz, Type II diabetes and metabolic syndrome in relation to head and neck squamous cell carcinoma risk: A SEER-Medicare database study, Cancer Epidemiology, 2013, 37, 4, 428

    CrossRef

  41. 41
    Ineke Meredith, Diana Sarfati, Takayoshi Ikeda, Tony Blakely, Cancer in Pacific people in New Zealand, Cancer Causes & Control, 2012, 23, 7, 1173

    CrossRef

  42. 42
    W.-Y. Kao, C.-Y. Hwang, Y.-T. Chang, C.-W. Su, M.-C. Hou, H.-C. Lin, F.-Y. Lee, S.-D. Lee, J.-C. Wu, Cancer risk in patients with pyogenic liver abscess: a nationwide cohort study, Alimentary Pharmacology & Therapeutics, 2012, 36, 5
  43. 43
    P. T. Campbell, C. C. Newton, A. V. Patel, E. J. Jacobs, S. M. Gapstur, Diabetes and Cause-Specific Mortality in a Prospective Cohort of One Million U.S. Adults, Diabetes Care, 2012, 35, 9, 1835

    CrossRef

  44. 44
    A. Vogel, M.P. Manns, Epidemiologie und molekulare Pathogenese des hepatozellulären Karzinoms, Der Gastroenterologe, 2012, 7, 5, 382

    CrossRef

  45. 45
    Biagio Arcidiacono, Stefania Iiritano, Aurora Nocera, Katiuscia Possidente, Maria T. Nevolo, Valeria Ventura, Daniela Foti, Eusebio Chiefari, Antonio Brunetti, Insulin Resistance and Cancer Risk: An Overview of the Pathogenetic Mechanisms, Experimental Diabetes Research, 2012, 2012, 1

    CrossRef

  46. 46
    Shintaro Fujihara, Hirohito Mori, Hideki Kobara, Noriko Nishiyama, Mitsuyoshi Kobayashi, Makoto Oryu, Tsutomu Masaki, Metabolic Syndrome, Obesity, and Gastrointestinal Cancer, Gastroenterology Research and Practice, 2012, 2012, 1

    CrossRef

  47. 47
    Marion Peyrou, Pierluigi Ramadori, Lucie Bourgoin, Michelangelo Foti, PPARs in Liver Diseases and Cancer: Epigenetic Regulation by MicroRNAs, PPAR Research, 2012, 2012, 1

    CrossRef